Back to the list
Congress: ECR25
Poster Number: C-20813
Type: Poster: EPOS Radiologist (educational)
Authorblock: M. Parillo, F. Vaccarino, V. Cirimele, G. D'Amone, C. C. Quattrocchi; Rovereto/IT
Disclosures:
Marco Parillo: Nothing to disclose
Federica Vaccarino: Nothing to disclose
Vincenzo Cirimele: Nothing to disclose
Giulia D'Amone: Nothing to disclose
Carlo Cosimo Quattrocchi: Nothing to disclose
Keywords: CNS, Management, Neuroradiology brain, MR, Education, Structured reporting, Cancer, Education and training, Neoplasia
Learning objectives To introduce radiologists to the Brain Tumor Reporting and Data System (BT-RADS). To collect the available literature regarding the use of BT-RADS for the surveillance of adult-type diffuse gliomas.
Read more Background Primary malignant brain tumors present significant challenges due to their unfavorable prognosis, high recurrence rates, and resistance to treatment. Regular follow-up using magnetic resonance imaging (MRI) is crucial for guiding the multidisciplinary team (MDT) management decisions, including surgery, radiation therapy, or alternative approaches. However, interpreting post-treatment MRI scans in gliomas can be quite demanding, for example, in identifying treatment-related changes (pseudoprogression) or medication-induced effects that may not accurately reflect tumor response (pseudoresponse). Additionally, the use of non-standardized language in MRI...
Read more Findings and procedure details BT-RADS scoreThe effective use of BT-RADS by radiologists requires the fulfillment of certain technical and clinical prerequisites: Brain MRI with fluid-attenuated inversion recovery (FLAIR) and contrast-enhanced T1-weighted images Clinical indications of post-treatment surveillance in patients with intra-axial primary brain cancers Knowledge of the surgical, radiation, and medication history BT-RADS employs a standardized numerical scoring system (0-4), with certain categories further subdivided (1a/1b, 3a/3b/3c) for precise assessment. Each score is directly linked to specific management recommendations [fig 1] BT-RADS 0: baseline study (initial diagnostic MRI or most...
Read more Conclusion To fully leverage the benefits of BT-RADS, comprehensive patient clinical information is essential. Additionally, widespread adoption of BT-RADS among all MDT members involved in primary brain tumor follow-up is crucial. Even if the final BT-RADS category isn't explicitly stated, the system serves as a valuable tool for interpreting imaging studies of patients undergoing brain tumor surveillance, warranting its familiarity among healthcare professionals.Preliminary studies suggest that BT-RADS offers several benefits for the surveillance of adult-type diffuse gliomas after treatment. These include...
Read more References Weinberg, B.D.; Gore, A.; Shu, H.-K.G.; Olson, J.J.; Duszak, R.; Voloschin, A.D.; Hoch, M.J. Management-Based Structured Reporting of Posttreatment Glioma Response with the Brain Tumor Reporting and Data System. J. Am. Coll. Radiol. JACR 2018, 15, 767–771. Brain Tumor Reporting and Data System (BT-RADS). Available online: https://btrads.com/ Parillo, M.; Quattrocchi, C.C. Brain Tumor Reporting and Data System (BT-RADS) for the Surveillance of Adult-Type Diffuse Gliomas after Surgery. Surgeries 2024, 5, 764-773. Ebaid, N.Y.; Ahmed, R.N.; Assy, M.M.; Amin, M.I.; Alaa Eldin, A.M.; Alsowey, A.M.; Abdelhay, R.M. Diagnostic Validity and...
Read more
GALLERY